Fidelity Investments’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$87.5M Sell
2,027,395
-148,404
-7% -$6.41M ﹤0.01% 1174
2025
Q1
$75.2M Buy
2,175,799
+554,204
+34% +$19.2M ﹤0.01% 1202
2024
Q4
$44.5M Sell
1,621,595
-198,727
-11% -$5.45M ﹤0.01% 1428
2024
Q3
$46.3M Buy
1,820,322
+280,409
+18% +$7.14M ﹤0.01% 1412
2024
Q2
$39M Sell
1,539,913
-785,699
-34% -$19.9M ﹤0.01% 1404
2024
Q1
$71.9M Sell
2,325,612
-88,729
-4% -$2.74M ﹤0.01% 1187
2023
Q4
$97.5M Sell
2,414,341
-13,181
-0.5% -$532K 0.01% 1023
2023
Q3
$61M Buy
2,427,522
+766,639
+46% +$19.3M 0.01% 1187
2023
Q2
$28.6M Sell
1,660,883
-443,351
-21% -$7.63M ﹤0.01% 1489
2023
Q1
$34.9M Buy
2,104,234
+1,401,129
+199% +$23.2M ﹤0.01% 1387
2022
Q4
$5.36M Sell
703,105
-280,244
-28% -$2.14M ﹤0.01% 2096
2022
Q3
$9.77M Buy
983,349
+2,987
+0.3% +$29.7K ﹤0.01% 1907
2022
Q2
$8.9M Buy
980,362
+3,165
+0.3% +$28.7K ﹤0.01% 2018
2022
Q1
$9.92M Sell
977,197
-204,839
-17% -$2.08M ﹤0.01% 2124
2021
Q4
$19.7M Sell
1,182,036
-506,114
-30% -$8.44M ﹤0.01% 1831
2021
Q3
$79.1M Buy
1,688,150
+301,462
+22% +$14.1M 0.01% 1204
2021
Q2
$84.5M Sell
1,386,688
-268,876
-16% -$16.4M 0.01% 1196
2021
Q1
$102M Buy
1,655,564
+244,293
+17% +$15M 0.01% 1059
2020
Q4
$100M Buy
1,411,271
+386,318
+38% +$27.5M 0.01% 1028
2020
Q3
$38.5M Sell
1,024,953
-523,943
-34% -$19.7M ﹤0.01% 1295
2020
Q2
$50.5M Sell
1,548,896
-78,356
-5% -$2.56M 0.01% 1157
2020
Q1
$47.2M Sell
1,627,252
-565,448
-26% -$16.4M 0.01% 1059
2019
Q4
$76.9M Sell
2,192,700
-444,438
-17% -$15.6M 0.01% 1026
2019
Q3
$56.6M Sell
2,637,138
-380,848
-13% -$8.18M 0.01% 1112
2019
Q2
$81.4M Buy
+3,017,986
New +$81.4M 0.01% 1001